You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Acute myeloid leukemia (AML)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial (ABBV-787)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Sep 29, 2023

AML, Adult Trial (STI-8591)

Not yet recruiting
  • AML, Adult
  • (no location specified)
Jul 12, 2023

Acute Myeloid Leukemia Trial in Cincinnati (CIML-NK Cells)

Recruiting
  • Acute Myeloid Leukemia
  • CIML-NK Cells
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Jan 4, 2023

Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Vienna, Austria
  • +3 more
Jun 8, 2023

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Granulocytic Sarcoma Trial in Winston-Salem (drug,

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • +2 more
  • CPI 613
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
May 10, 2023

Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

Not yet recruiting
  • Acute Myeloid Leukemia
    • (no location specified)
    Sep 22, 2023

    Novel Digital Array PCR for Acute Myeloid Leukemia (AML)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Minimal Residual Disease
      • Chapel Hill, North Carolina
        North Carolina Cancer Hospital (NCCH)
      Feb 2, 2023

      iN the Real Practice

      Not yet recruiting
      • Acute Myeloid Leukemia (AML)
      • +2 more
      • Vyxeos liposomal
      • Roma, Italy
        Policlinico Tor Vergata
      Nov 16, 2023

      Healthcare Resource Utilization in Adults Diagnosed With Acute

      Completed
      • Acute Myeloid Leukemia (AML)
      • Helsinki, Finland
        Novartis Investigative Site
      Aug 3, 2022

      MDS, Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial in Pittsburgh (IFN-? (interferon gamma-1b) injection)

      Recruiting
      • Myelodysplastic Syndromes
      • +2 more
      • IFN-γ (interferon gamma-1b) injection
      • Pittsburgh, Pennsylvania
        UPMC Hillman Cancer Center
      Jan 5, 2023

      AML, Adult, Minimal Residual Disease Trial in Tianjin (CD33/CLL1 dual CAR-NK cell, Cyclophosphamid, Fludarabine)

      Not yet recruiting
      • AML, Adult
      • Minimal Residual Disease
      • CD33/CLL1 dual CAR-NK cell
      • +5 more
      • Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Aug 4, 2023

      Acute Myeloid Leukemia (AML) Trial in Birmingham, San Francisco, New York (ZN-d5 ZN-c3, ZN-c3)

      Recruiting
      • Acute Myeloid Leukemia (AML)
      • Birmingham, Alabama
      • +2 more
      Jan 3, 2023

      UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Wuhan (Basic

      Recruiting
      • UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
      • Basic chemotherapy + UCB transplantation
      • Wuhan, Hubei, China
        Zhongnan Hospital of Wuhan University
      Oct 9, 2022

      Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)

      Recruiting
      • Acute Myeloid Leukemia
      • Venclexta 100 MG Oral Tablet
      • Nanjing, Jiangsu, China
        The First Affiliated Hospital with Nanjing Medical University
      Jun 11, 2023

      Acute Myeloid Leukemia Trial in Suzhou (Venetoclax Oral Tablet, Daunorubicin)

      Recruiting
      • Acute Myeloid Leukemia
      • Suzhou, Jiangsu, China
      • +1 more
      Jul 3, 2023

      Acute Myeloid Leukemia Trial in Baltimore, Houston (Atovaquone, Cytarabine, Daunorubicin)

      Active, not recruiting
      • Acute Myeloid Leukemia
      • Baltimore, Maryland
      • +1 more
      Oct 7, 2022

      Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) Trial in Guediawaye GOL SUD (Pyronaridine Tetraphosphate)

      Recruiting
      • Acute Myeloid Leukemia (AML)
      • Acute Lymphoblastic Leukemia (ALL)
      • Pyronaridine Tetraphosphate
      • Guediawaye GOL SUD, Dakar, Senegal
        Dalal Jamm Hospital
      Nov 23, 2022

      Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in Gainesville (Ciprofloxacin 750 MG, Etoposide,

      Terminated
      Has Results
      • Leukemia
      • +2 more
      • Ciprofloxacin 750 MG
      • +3 more
      • Gainesville, Florida
        UF Health Shands Cancer Hospital
      Jul 5, 2022

      Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Chengdu (SKLB1028 Dose Escalation)

      Recruiting
      • Newly Diagnosed Acute Myeloid Leukemia (AML)
      • SKLB1028 Dose Escalation
      • Chengdu, China
        West China Hospital of Sichuan University
      Jun 30, 2022

      Acute Myeloid Leukemia Trial (WU-NK-101)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • WU-NK-101
      • (no location specified)
      Jul 20, 2022

      Leukemia, Myeloid, Acute Trial (Cytarabine, Venetoclax, CPX-351)

      Not yet recruiting
      • Leukemia, Myeloid, Acute
      • (no location specified)
      Nov 25, 2022

      AML, Acute Myeloid Leukemia Trial in Boston (DREAMLAND, CERENA)

      Not yet recruiting
      • AML
      • Acute Myeloid Leukemia
      • DREAMLAND
      • CERENA
      • Boston, Massachusetts
        Massachusetts General Hospital
      Aug 12, 2022

      Leukemia, Myeloid, Acute, AML Stage, Adult Trial in Xiamen (Venetoclax Combining Chidamide and Azacitidine (VCA) regimen

      Not yet recruiting
      • Leukemia, Myeloid, Acute
      • AML Stage, Adult
      • Venetoclax Combining Chidamide and Azacitidine (VCA) regimen followed by dicitabine combined with liposome mitoxantrone, cytarabine, and G-CSF (D-MAG) regimen
      • Xiamen, Fujian, China
        Bing Xu
      Oct 29, 2022

      Acute Myeloid Leukemia With FLT3/ITD Mutation Trial (XY0206, Salvage Chemotherapy)

      Not yet recruiting
      • Acute Myeloid Leukemia With FLT3/ITD Mutation
      • (no location specified)
      May 24, 2023

      Adverse Events and Change in Disease Activity in Participants

      Recruiting
      • Acute Myeloid Leukemia (AML)
        • Seoul, Seoul Teugbyeolsi, Korea, Republic of
        • +5 more
        Nov 4, 2022